Clinical Trials Directory

Trials / Completed

CompletedNCT01544959

Postoperative Analgesia Impact of Narcotic Free Anesthesia

The Impact on Postoperative Pain of Substituting Opioids by Beta Blockers for Peroperative Hemodynamic Control in Patients Undergoing Mastectomy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
84 (estimated)
Sponsor
Université de Sherbrooke · Academic / Other
Sex
Female
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The first hypothesis of the study is that substituting fentanyl by esmolol and metoprolol during general anesthesia for patients undergoing mastectomy will result in less pain and less narcotic consumption in the recovery room. The investigators will also verify the impact of that substitution on nausea and vomiting, on the time spent in the recovery room and on chronic postsurgical pain (3 and 6 months). Finally, the investigators will see the impact on breast cancer recurrence 5 years after the surgery.

Conditions

Interventions

TypeNameDescription
DRUGfentanylUse of esmolol and metoprolol compared to use of fentanyl for hemodynamic control during general anesthesia. At induction, fentanyl (2 mcg/kg) is replaced by esmolol (1 mg/kg). During the case, with a standardised anesthesia, response to surgical stimulation will be medicated either by fentanyl (50 mcg aliquot) or metropolol (2.5 mg), for a maximum of 6 doses. After this, fentanyl will be given unblindly.
DRUGbeta-blocker (esmolol, metropolol)esmolol is used at induction and lopressor during surgery instead of fentanyl in response to surgical stimulation.

Timeline

Start date
2010-01-01
Primary completion
2013-01-01
Completion
2018-05-01
First posted
2012-03-06
Last updated
2018-10-24

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01544959. Inclusion in this directory is not an endorsement.

Postoperative Analgesia Impact of Narcotic Free Anesthesia (NCT01544959) · Clinical Trials Directory